Histogenics Corporation (HSGX) shares rallied strongly today. The stock traded nearly 32 million shares as of 2 PM EST, and could potentially exceed 40 million shares by the close. As of the time this content was created, the stock was up over 36%. It is not immediately clear why shares are moving today, but I […]
Read Article
Two stocks in the biotech space had dramatic moves over the last two days. One in Trevena Inc (TRVN), which moved from about $0.60 to nearly $1.50 per share over the last two days. The stock was up due to news of a pathway to possible FDA approval for its flagship product. The other big […]
Read Article
The healthcare and biotech sectors were both bearish today. The overall US equities market declined over 1% during the session, as the markets were unable to find positive news catalysts in the wake of negative earnings results in major names in multiple sectors. This suggests that the markets are beginning to re-evaluate current stock valuations, […]
Read Article
Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass
Read Article
Corcept Therapeutics (CORT) shares were down sharply due to a negative report published by the Southern Investigative Reporting Foundation. In the report, the SIRF laid out an argument essentially accusing the company of colluding with physicians to increase prescriptions of its treatment despite the fact that the treatment was only approved by the FDA for […]
Read Article
Capricor Therapeutics Inc. (CAPR) shares slumped sharply after spiking prior to market open. Shares of the stock were up due to the company highlighting a report detailing significant improvements for muscular dystrophy patients treated with the company’s cell therapy. However, it was noted shortly thereafter by some traders that the report was published back in […]
Read Article
Altimmune Inc. ($ALT) shares traded sharply higher today after patent news. The company’s immunologic-therapeutic was granted a US patent today, potentially setting up the stock for an extended bull run. However, the company has a significant financial strain and no products at phase 3 status, so obtaining additional funding will be an issue. Here’s a […]
Read Article
Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass
Read Article
Bio-Path Holdings Inc. (BPTH) was very active in trading today. The company surprised the markets by executing a 1:20 reverse split before today’s open. A reverse split means the company converted every 20 shares into 1 share, adjusting the price of the stock to equal 20X yesterday’s close. This meant the price per share went […]
Read Article
Lipocine Inc (LPCN) slumped after opening sharply higher today. The stock rallied in the pre-market due to the company releasing a report detailing apparently positive indications for LPCN for its potential in the treatment of liver fat in hypogonadal males. However, biotech columnist Adam Feuerstein voiced negative comments, stating that he believes the study was […]
Read Article
